Compliance Is Good Business

DID YOU KNOW whistle-blowers who bring actions against pharmaceutical companies under the false claims act can be entitled to 25 to 30 percent of any settlement? Mary E. Riordan, senior counsel, Office of Inspector General, presented that startling information at her session about the OIG's pharma marketing compliance program during the Annual Conference of the National Task Force on CME Provider/Industry Collaboration, held in September. Whistle-blowers, she said, initiated the recent